Cargando…
The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure against deliberate use of high-consequence viral hemorrhagic fevers (VHFs) in 2016. The effort featured comprehensive preclinical...
Autores principales: | Hickman, Mark R., Saunders, David L., Bigger, Catherine A., Kane, Christopher D., Iversen, Patrick L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903284/ https://www.ncbi.nlm.nih.gov/pubmed/35259154 http://dx.doi.org/10.1371/journal.pntd.0010220 |
Ejemplares similares
-
Autophagy, antiviral immunity, and viral countermeasures
por: Shoji-Kawata, Sanae, et al.
Publicado: (2009) -
Hemorrhagic Fever Viruses: Pathogenesis and Countermeasures
por: Mire, Chad E., et al.
Publicado: (2022) -
Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015) -
Activation of the Antiviral Kinase PKR and Viral Countermeasures
por: Dauber, Bianca, et al.
Publicado: (2009) -
Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)